Sunnyvale, CA, United States of America

Steve Yanofsky

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Tosk, Incorporated. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Steve Yanofsky: Innovator in Transgenic Animal Models

Introduction

Steve Yanofsky is a notable inventor based in Sunnyvale, California. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic animal models. His work focuses on innovative approaches to understanding cellular proliferative diseases.

Latest Patents

Steve Yanofsky holds a patent for a Non-mammalian RAS transgenic animal model. This invention involves non-mammalian, transgenic animals, such as flies, that include a RAS transgene. The patent also outlines methods for using these transgenic non-mammalian animals to identify compounds that have activity concerning cellular proliferative diseases, including neoplastic conditions.

Career Highlights

Throughout his career, Steve has been associated with Tosk, Incorporated, where he has contributed to various research initiatives. His expertise in transgenic models has positioned him as a valuable asset in the biotechnology sector.

Collaborations

Steve has collaborated with notable colleagues, including Travis Karg and William A. Garland. Their combined efforts have advanced research in the field and fostered innovation in transgenic technology.

Conclusion

Steve Yanofsky's work in developing non-mammalian transgenic animal models represents a significant advancement in biotechnology. His contributions continue to influence research in cellular proliferative diseases and highlight the importance of innovative approaches in scientific discovery.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…